{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:49:56Z","timestamp":1766407796395},"reference-count":8,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T00:00:00Z","timestamp":1669507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T00:00:00Z","timestamp":1669507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-022-02488-z","type":"journal-article","created":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T11:28:05Z","timestamp":1669548485000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of sarcoidosis with psoriasis: a cross-sectional study in the All of Us research program"],"prefix":"10.1007","author":[{"given":"Michael J.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey C.","family":"Leasure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Damsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,27]]},"reference":[{"issue":"5","key":"2488_CR1","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/art.10935","volume":"48","author":"J Balding","year":"2003","unstructured":"Balding J, Kane D, Livingstone W et al (2003) Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. Arthritis Rheum 48(5):1408\u20131413. https:\/\/doi.org\/10.1002\/art.10935","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2488_CR2","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","volume":"13","author":"RP Baughman","year":"2016","unstructured":"Baughman RP, Field S, Costabel U et al (2016) Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc 13(8):1244\u20131252. https:\/\/doi.org\/10.1513\/AnnalsATS.201511-760OC","journal-title":"Ann Am Thorac Soc"},{"issue":"10","key":"2488_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109632","volume":"9","author":"U Khalid","year":"2014","unstructured":"Khalid U, Gislason GH, Hansen PR (2014) Sarcoidosis in patients with psoriasis: a population-based cohort study. PLoS ONE 9(10):e109632. https:\/\/doi.org\/10.1371\/journal.pone.0109632","journal-title":"PLoS ONE"},{"issue":"10","key":"2488_CR4","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1007\/s10038-007-0185-7","volume":"52","author":"I Medica","year":"2007","unstructured":"Medica I, Kastrin A, Maver A, Peterlin B (2007) Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis. J Hum Genet 52(10):836\u2013847. https:\/\/doi.org\/10.1007\/s10038-007-0185-7","journal-title":"J Hum Genet"},{"key":"2488_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.12.010","author":"MJ Murphy","year":"2020","unstructured":"Murphy MJ, Cohen JM, Vesely MD, Damsky W (2020) Paradoxical eruptions to targeted therapies in dermatology: a systematic review and analysis. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2020.12.010","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2488_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1365-2133.2007.07993.x","volume":"157","author":"B Nedoszytko","year":"2007","unstructured":"Nedoszytko B, Szczerkowska-Dobosz A, Zab\u0142otna M, Gle\u0144 J, Reba\u0142a K, Roszkiewicz J (2007) Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population. Br J Dermatol 157(1):165\u2013167. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07993.x","journal-title":"Br J Dermatol"},{"key":"2488_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.009","author":"EB Wallace","year":"2018","unstructured":"Wallace EB, Khosravi H, Joyce CJ, Vleugels FR, Patel M (2018) Examining the epidemiology of coincident psoriasis and sarcoidosis: an observational cross-sectional study. J Am Acad Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.009","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"2488_CR8","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1001\/jamadermatol.2013.4256","volume":"149","author":"KA Wanat","year":"2013","unstructured":"Wanat KA, Schaffer A, Richardson V, VanVoorhees A, Rosenbach M (2013) Sarcoidosis and psoriasis: a case series and review of the literature exploring co-incidence vs coincidence. JAMA Dermatol 149(7):848\u2013852. https:\/\/doi.org\/10.1001\/jamadermatol.2013.4256","journal-title":"JAMA Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02488-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02488-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02488-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T11:28:40Z","timestamp":1669548520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02488-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,27]]},"references-count":8,"alternative-id":["2488"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02488-z","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,27]]},"assertion":[{"value":"26 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"WD is a consultant for Pfizer, Incyte, Eli Lilly, and TWi Biotechnology, has research funding from Pfizer, Advanced Cell Diagnostics\/Bio-techne, and AbbVie and receives licensing fees from EMD\/Millipore\/Sigma. JMC serves on a data and safety monitoring board for Advarra. MJM and ACL have no conflicts to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study (2000030542) has been deemed not to be human subjects research by the Yale University Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinicaltrials.gov (or equivalent) listing (if applicable)"}}]}}